Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes)

Journal of Applied Toxicology : JAT
G S BehonickS I Baskin

Abstract

This toxicology update reviews the oxidative stress metabolites of catecholamines, postulated to be the biochemical initiators of cardiotoxicity. A brief overview of catecholamine metabolism is provided with several noteworthy historical observations relating to the autoxidation and rearrangement of epinephrine. The basic chemical and physical properties of adrenochrome and adrenolutin are discussed. The autoxidative, enzymatic and cellular basis for the transformation of catecholamines to oxidative metabolites is reviewed. Mechanisms seeking to account for the observed cardiotoxic changes in isolated heart perfusion studies and in vivo models are described.

References

Nov 1, 1975·Journal of Molecular and Cellular Cardiology·J C Yates, N S Dhalla
Jan 1, 1978·Journal of Molecular and Cellular Cardiology·N S DhallaA Singh
Jan 1, 1990·Pharmacology & Therapeutics·W B Parker, Y C Cheng
Oct 1, 1990·Clinical Pharmacology and Therapeutics·B BoudíkováR Weinshilboum
Jul 1, 1989·Toxicology Letters·A BindoliL Galzigna
Jan 1, 1989·Critical Reviews in Clinical Laboratory Sciences·K Nyyssönen, M T Parviainen
May 4, 1989·Molecular and Cellular Biochemistry·K S DhallaN S Dhalla
Apr 1, 1985·Journal of Molecular and Cellular Cardiology·S B MatthewsA K Campbell
Apr 1, 1985·Journal of Molecular and Cellular Cardiology·G Rona
Apr 1, 1985·Journal of Molecular and Cellular Cardiology·A M WheatleyL H Opie
Jan 1, 1971·Biochemical Pharmacology·D M Valerino, J J McCormack
Mar 1, 1968·The Biochemical Journal·J W Bridges, R T Williams
Jan 15, 1981·Biochemical Pharmacology·S TakeoN S Dhalla
Jan 31, 1980·The New England Journal of Medicine·UNKNOWN Anturane Reinfarction Trial Research Group
Jul 29, 1995·Lancet·H MoritaS Mimura
Aug 1, 1994·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·T KarhunenP Panula
Jun 1, 1960·The American Journal of Medicine·O W BEARDL G BERAN
Jun 1, 1962·Biochemical Pharmacology·J J NOVALA C BRYAN
Apr 1, 1937·The Biochemical Journal·D E Green, D Richter
Jan 15, 1940·The Journal of Physiology·F J Philpot
Mar 14, 1940·The Journal of Physiology·H Blaschko, H Schlossmann

❮ Previous
Next ❯

Citations

Aug 5, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shi-Sheng ZhouYong-Zhi Lun
Aug 8, 2009·Antioxidants & Redox Signaling·Paul W Buehler, Felice D'Agnillo
Oct 9, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Christopher R DanielsKrishna Singh
Jul 9, 2010·Future Cardiology·Robert R Attaran, Gordon A Ewy
Jan 9, 2014·Heart Failure Reviews·Lucas LiaudetPal Pacher
Sep 22, 2009·Canadian Journal of Physiology and Pharmacology·Adriana AdameovaNaranjan S Dhalla
Dec 17, 2015·The American Journal of Emergency Medicine·Giolanda VarvarousiHlias Pavlou
Feb 13, 2003·Biomedical Chromatography : BMC·Fernando RemiãoA Ferrer-Correia
Jan 30, 2016·Oxidative Medicine and Cellular Longevity·Manuela GrazianiLuciano Saso
Dec 15, 2015·Canadian Journal of Physiology and Pharmacology·Vineet GoyalNaranjan S Dhalla
Nov 11, 2008·Toxicology·Premysl MladenkaRadomír Hrdina
May 25, 2007·Pharmacology & Therapeutics·Peter E PensonKenneth J Broadley
Jan 16, 2007·Journal of Molecular and Cellular Cardiology·Marc IsabelleChristelle Monteil
Aug 18, 2004·Fundamental & Clinical Pharmacology·Fabienne MoritzChristian Thuillez
Mar 21, 2007·Journal of Cellular and Molecular Medicine·Margherita NeriVittorio Fineschi
Feb 17, 2015·European Journal of Heart Failure·Andrea FrustaciCristina Chimenti
Jan 20, 2009·Annales d'endocrinologie·F LucaJ-L Schlienger
May 19, 2005·Revista española de cardiología·Miguel Yebra YebraSantiago Prieto
Jan 7, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Andrea CabarkapaBiljana Spremo-Potparević
Sep 18, 2016·Heart Failure Clinics·Giuseppe LimongelliGiuseppe Pacileo
Jun 14, 2017·Circulation·Francesco PellicciaPaolo G Camici
Nov 16, 2004·Journal of Applied Physiology·F HaddadG R Adams
Jul 20, 2007·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Alexander V LebedevEnno K Ruuge
Dec 24, 2019·Free Radical Research·Gagan B N Chainy, Dipak Kumar Sahoo
Sep 17, 2020·Human & Experimental Toxicology·S ZareG Karimi
Dec 15, 2010·American Journal of Therapeutics·Sandeep Bhargava, Rohit R Arora
Dec 7, 2018·Nanomedicine·Chandraiah GoduguAmit Khurana
Mar 14, 2019·Arhiv za higijenu rada i toksikologiju·Dijana TopalovićLada Živković
Dec 26, 2018·Oxidative Medicine and Cellular Longevity·Milena RadakovićZoran Stanimirović
Mar 27, 2019·Canadian Journal of Physiology and Pharmacology·Naranjan S DhallaParamjit S Tappia
Jan 3, 2021·Cardiovascular Toxicology·Larissa Andrade de Sá FeitosaAndré Sales Barreto
Dec 17, 2019·Journal of Cardiothoracic and Vascular Anesthesia·Alessandro BellettiSilvia Ajello
Dec 22, 2020·World Journal of Clinical Cases·Qi WangXian-Hong Shu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.